2019
DOI: 10.30773/pi.2018.12.19.1
|View full text |Cite
|
Sign up to set email alerts
|

Peripheral Biomarkers for First-Episode Psychosis—Opportunities from the Neuroinflammatory Hypothesis of Schizophrenia

Abstract: Objective Schizophrenia is a disabling disorder of unknown aetiology, lacking definite diagnostic method and cure. A reliable biological marker of schizophrenia is highly demanded, for which traceable immune mediators in blood could be promising candidates. We aimed to gather the best findings of neuroinflammatory markers for first-episode psychosis (FEP). Methods We performed an extensive narrative review of online literature on inflammation-related markers found in hu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
22
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 42 publications
(25 citation statements)
references
References 124 publications
2
22
0
1
Order By: Relevance
“…We found that IFNy level showed a significant correlation with PANSS-total, PANSS-positive, PANSS-general subscores, and CGI score, thus IFNy level could be an indicative marker of disease severity in schizophrenia. IL-8 is an inflammatory chemokine significantly upregulated in the dorsolateral prefrontal cortex of individuals with schizophrenia (24) and a peripheral inflammatory biomarker found in FEP patients (25) and in multiple-episode schizophrenia (MES) patients (24). A significant positive correlation was shown between serum concentration of IL-8 The serum concentration of OPN was significantly decreased (p = 0.021) in patients on long-term antipsychotic therapy (8.8 ± 5.9 years) compared to patients on short-term therapy (3.5 ± 1.9 weeks).…”
Section: Discussionmentioning
confidence: 99%
“…We found that IFNy level showed a significant correlation with PANSS-total, PANSS-positive, PANSS-general subscores, and CGI score, thus IFNy level could be an indicative marker of disease severity in schizophrenia. IL-8 is an inflammatory chemokine significantly upregulated in the dorsolateral prefrontal cortex of individuals with schizophrenia (24) and a peripheral inflammatory biomarker found in FEP patients (25) and in multiple-episode schizophrenia (MES) patients (24). A significant positive correlation was shown between serum concentration of IL-8 The serum concentration of OPN was significantly decreased (p = 0.021) in patients on long-term antipsychotic therapy (8.8 ± 5.9 years) compared to patients on short-term therapy (3.5 ± 1.9 weeks).…”
Section: Discussionmentioning
confidence: 99%
“…Table 3 presents CSF cytokine levels in patients with schizophrenia. Based on the available meta-analytical data, it is hypothesized that there is a certain disturbance in the balance between pro-inflammatory cytokines, such as interleukin-6 (IL-6) or IL-1β, and anti-inflammatory cytokines such as interleukin 10 (IL-10) [6,29]. This hypothesis is supported by the protective effect of Th2 cytokines and anti-inflammatory cytokines, whose elevated prenatal levels in the maternal blood may reduce the risk of schizophrenia in the offspring [30,31].…”
Section: Cytokines and Schizophreniamentioning
confidence: 99%
“…In ASD, immune disturbances have been detected from childhood [31,32] through to adulthood [33] (reviewed in [34]). Similarly, in schizophrenia, cytokine changes are being considered as potential biological markers, as differential profiles have been detected across disease states (reviewed in [35]).…”
Section: Introductionmentioning
confidence: 99%